These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 10360220

  • 21. CA 242 is a new tumor marker for pancreatic cancer.
    Röthlin MA, Joller H, Largiadèr F.
    Cancer; 1993 Feb 01; 71(3):701-7. PubMed ID: 8431849
    [Abstract] [Full Text] [Related]

  • 22. Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique.
    Bloomston M, Bhardwaj A, Ellison EC, Frankel WL.
    Dig Surg; 2006 Feb 01; 23(1-2):74-9. PubMed ID: 16717472
    [Abstract] [Full Text] [Related]

  • 23. Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.
    Hurtado M, Lozano JJ, Castellanos E, López-Fernández LA, Harshman K, Martínez-A C, Ortiz AR, Thomson TM, Paciucci R.
    Gut; 2007 Sep 01; 56(9):1266-74. PubMed ID: 17452424
    [Abstract] [Full Text] [Related]

  • 24. Neopterin serum levels in pancreatic adenocarcinoma.
    Manes G, Spada OA, Rabitti PG, Feola B, Misso S, Minerva A, Uomo G.
    Int J Pancreatol; 1999 Feb 01; 25(1):31-7. PubMed ID: 10211419
    [Abstract] [Full Text] [Related]

  • 25. Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer?
    Kayhan B, Kayhan B, Akdoğan M.
    Int J Biol Markers; 2004 Feb 01; 19(3):196-202. PubMed ID: 15503821
    [Abstract] [Full Text] [Related]

  • 26. Inflammation, Tumoral Markers and Interleukin-17, -10, and -6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis.
    Tanţău A, Leucuţa DC, Tanţău M, Boţan E, Zaharie R, Mândruţiu A, Tomuleasa IC.
    Dig Dis Sci; 2021 Oct 01; 66(10):3427-3438. PubMed ID: 33184795
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases.
    Plebani M, Basso D, Fabris C, Meggiato T, Del Favero G, Panozzo MP, Fogar P, Faggian D, Angonese C, Burlina A.
    Klin Wochenschr; 1989 Oct 17; 67(20):1029-32. PubMed ID: 2586008
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A, Encabo G.
    Rev Esp Oncol; 1983 Oct 17; 30(3):313-6. PubMed ID: 6571374
    [Abstract] [Full Text] [Related]

  • 31. Clinical significance of EGF and EGFR expression changes in cryptorchid boys.
    Yang GS, Lu RK, Chen ZD.
    Asian J Androl; 2002 Dec 17; 4(4):255-8. PubMed ID: 12508124
    [Abstract] [Full Text] [Related]

  • 32. Urinary epidermal growth factor (EGF) levels and epidermal growth factor receptor (EGF-R) expression in human cerebral tumors. Clinical considerations.
    Bello L.
    J Neurosurg Sci; 1996 Dec 17; 40(3-4):167-82. PubMed ID: 9165424
    [Abstract] [Full Text] [Related]

  • 33. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer.
    Uegaki K, Nio Y, Inoue Y, Minari Y, Sato Y, Song MM, Dong M, Tamura K.
    Anticancer Res; 1997 Dec 17; 17(5B):3841-7. PubMed ID: 9427790
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
    Pryczynicz A, Guzińska-Ustymowicz K, Kemona A, Czyzewska J.
    Anticancer Res; 2008 Dec 17; 28(2B):1399-404. PubMed ID: 18505086
    [Abstract] [Full Text] [Related]

  • 36. Can plasma human pancreatic polypeptide be used to detect diseases of the exocrine pancreas?
    Koch MB, Go VL, DiMagno EP.
    Mayo Clin Proc; 1985 Apr 17; 60(4):259-65. PubMed ID: 2984484
    [Abstract] [Full Text] [Related]

  • 37. EGFR genomic gain and aberrant pathway signaling in pancreatic cancer patients.
    Tzeng CW, Frolov A, Frolova N, Jhala NC, Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ, Arnoletti JP.
    J Surg Res; 2007 Nov 17; 143(1):20-6. PubMed ID: 17950068
    [Abstract] [Full Text] [Related]

  • 38. [Value of plasma testosterone, carcinoembryonic antigen and CA 19-9 in the differential diagnosis of pancreatic carcinoma and chronic pancreatitis].
    Jurkowska G, Kulpa J, Skrodzka D, Rogowski F.
    Pol Arch Med Wewn; 1992 Nov 17; 88(5):302-9. PubMed ID: 1300550
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA, Dehlendorff C, Jensen BV, Bjerregaard JK, Nielsen KR, Bojesen SE, Calatayud D, Nielsen SE, Yilmaz M, Holländer NH, Andersen KK, Johansen JS.
    JAMA; 1992 Nov 17; 311(4):392-404. PubMed ID: 24449318
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.